Experimental evaluation of potential anticancer agents. XXI. Scheduling of arabinosylcytosine to take advantage of its S-phase specificity against leukemia cells.

Cancer chemotherapy reports ·Vol. 51 ·No. 3 ·1967-06-00 ·Pages 125-65

Skipper HE, Schabel FM, Wilcox WS

Abstract

暂无摘要

MeSH Terms

Animals Antimetabolites/administration & dosage,pharmacology Cell Division Cytarabine/administration & dosage,pharmacology DNA, Neoplasm/biosynthesis Leukemia L1210/metabolism Mice Thymidine/metabolism Tritium

Chemicals

Antimetabolites DNA, Neoplasm Cytarabine Tritium Thymidine

Authors & Affiliations

3 authors, click to expand affiliations / ORCID

Skipper H E

Schabel F M

Wilcox W S

Article Info

Journal

Cancer chemotherapy reports

Abbr.

Cancer Chemother Rep

ISSN

0069-0112

Published

1967-06-00

Pages

125-65

Language

English

Region

United States

NLM ID

7607105

Subset

External Links

PubMed source

Analysis Services

Experimental evaluation of potential anticancer agents. XXI. Scheduling of arabinosylcytosine to take advantage of its S-phase specificity against leukemia cells.

Contact

WeChat Official Account